NDC 55111-193 is a in the category. It is labeled and distributed by .
| Proprietary Name | NDC 55111-193 |
| Marketing Category | / |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2011-01-25 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |
| Marketing Category | ANDA |
| Application Number | ANDA076502 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2006-04-12 |
| Marketing End Date | 2011-01-25 |